X
Staff Correspondent

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

  • Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
  • Net sales decreased 41% to $58.3 million
  • Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript

Categories: AlphaGraphs Earnings Health Care
Tags: Medical Devices
Related Post
  1. Yum! Brands (YUM) Q3 2024 Earnings: Key financials and quarterly highlights

    Yum! Brands, Inc. (NYSE: YUM) reported its third quarter 2024 earnings results today. Total revenues…

  2. Earnings Summary: Highlights of Loews Corporation’s (L) Q3 2024 report

    Loews Corporation (NYSE: L), a diversified company with businesses in the insurance, energy, hospitality, and…

  3. Earnings Summary: A snapshot of Fidelity National’s Q3 2024 report

    Fidelity National Information Services, Inc. (NYSE: FIS), a provider of technology solutions for financial institutions…

PRODUCTS

ABOUT US

GROUPS